The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids

Journal of the Medical Association of Thailand

Volumn 90, Issue 7, 2007, Pages 1363-1367

  Chuangsuwanich, Apirag ^a   Gunjittisomrarn, Suriya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Imiquimod; Keloid; Scar

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT; INTERFERON INDUCING AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY REGIONS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; EXCISION; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; KELOID; MALE; POSTOPERATIVE PERIOD; PROPHYLAXIS; RECURRENT DISEASE; SCHOOL CHILD; SKIN ABRASION; SUTURING METHOD; WOUND; CHILD; CLINICAL TRIAL; DRUG EFFECT; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDY; TIME; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOQUINOLINES; CHILD; FEMALE; HUMANS; INTERFERON INDUCERS; KELOID; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; WOUND HEALING;

EID: 34548531478     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-58.
2. Broughton G, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg 2006; 117(7 Suppl): 1e-S-32e-S.
3. Poochareon VN, Berman B. New therapies for the management of keloids. J Craniofac Surg 2003; 14: 654-7.
4. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992; 45: 374-9.
5. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002; 47(4 Suppl): S209-11.
6. Chang YC, Madkan V, Cook-Norris R, Sra K, Tyring S. Current and potential uses of imiquimod. South Med J 2005; 98: 914-20.
7. Dahl MV. Imiquimod: a cytokine inducer. J Am Acad Dermatol 2002; 47(4 Suppl): S205-8.
8. Kischer CW, Shetlar MR, Shetlar CL. Alteration of hypertrophic scars induced by mechanical pressure. Arch Dermatol 1975; 111: 60-4.
9. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30: 506-7.
10. Chuangsuwanich A, Osathalert V, Muangsombut S. Self-adhesive silicone gel sheet: a treatment for hypertrophic scars and keloids. J Med Assoc Thai 2000; 83: 439-44.
11. Malaker K, Zaidi M, Franka MR. Treatment of earlobe keloids using the cobalt 60 teletherapy unit. Ann Plast Surg 2004; 52: 602-4.
12. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755-7.
13. Davison SP, Mess S, Kauffman LC, Al Attar A. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg 2006; 117: 247-52.
14. Jacob SE, Berman B, Nassiri M, Vincek V. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis. Br J Dermatol 2003; 149(Suppl 66): 62-5.